Skip to main content

Table 4 Biochemistry before and after treatment

From: High output cardiac failure in 3 patients with hereditary hemorrhagic telangiectasia and hepatic vascular malformations, evaluation of treatment

 

Patient 1

Patient 2

Patient 3

Before

After OLT

9-months

Before

After BVZ

9-months

Before

After BVZ

9-months

Hemoglobin (g/L)

127.3

104.7

101.5

72.5

114.4

104.7

98.3

161.4

136.9

ALAT (U/L)

18

121

44

18

23

21

44

38

45

ALP (U/L)

89

215

232

112

117

100

125

85

100

Bilirubin (mg/dL)

0.58

1.05

0.7

0.88

–

–

1.4

1.58

25

INR

1.2

1.0

–

1.4

–

–

1.1

1.5

1.2

Bevacizumab side effects

No bevacizumab

Vulnerable and flossy nails

Dry, itchy skin, alopecia

  1. OLT orthotopic liver transplantation, BVZ bevacizumab, ALAT alanine aminotransferase, ALP alkaline phosphatase, INR international normalized ratio